Branding

1
(No Transcript)
2
Update on DTI activities and priorities in
Bioscience Ian Young DTI Bioscience Unit March
2005
3

• UK Biotechnology Industry
• Bioscience Innovation and Growth Team
• Healthcare Industry Task Force
• Funding Streams
• Partners

4

• 1. UK Biotechnology Industry

5
UK Biotechnology statistics 2003

• 455 companies (2002 494)
• Employs 22,400 people (2002 24,400)
• 224 new drugs in clinical development or awaiting
  approval
• 3.6billion of revenue (2002 3.4 billion)
• Raised 392 million of equity investment (2002
  440 million)
• Spent 1.24bn on RD (2003 1.41bn)
• Source Critical I Ltd for DTI, 2005

6

• 2. Bioscience Innovation and Growth Team

7
Bioscience Innovation and Growth Team (BIGT)

• Industry/Government Task Force set up November
  2002 reported November 2003 Government Response
  May 2004
• DTI in lead DH involved
• Vision By 2015, UK will have secured its
  position a global leader in Bioscience

8
Main BIGT outcomes to date

• Bioscience Leadership Council (Sir Richard
  Sykes)
• Budget announcement of increased spending on NHS
  RD for clinical trials, and the UK Clinical
  Research Collaboration (UKCRC)
• Bioprocessing Knowledge Transfer Network
• Biosciences Futures Forum (Gill Samuels - Pfizer)
• Myners Study on pre-emption rights
• Further Legislation on Animal Rights Extremists

9

• 3. Healthcare Industry Task Force

10
Healthcare Industry Task Force (HITF)

• Industry/Government Task Force set up November
  2003 reported November 2004 Government Response
  May 2004
• DH in lead DTI involved
• Aim - identify steps to develop, stimulate the
  growth and performance of the UK healthcare
  industry and maximise the benefit to patients
  from healthcare products.

11
Healthcare Industry Task Force
(HITF)recommendations

• New Device Evaluation Service
• NHS National Innovation Centre
• Better NHS procurement processes
• Improve NHS RD Capacity
• Healthcare Technology Cooperative
• Better patient understanding of risk/benefit
  ratios
• Improve NHS training on use of advanced devices

12

• 4. Funding Streams

13
Government Financial Support

• Technology Programme Collaborative RD,
  Knowledge Transfer Networks
• Small company RD
• Increasing support for science - 4.9bn by
  2007/2008
• Higher Education Innovation Fund
• RD Tax Credits
• but no biotech-specific schemes

14

• 5. Partners

15
Bioscience Unit partners

• Companies Business Relations role
• Industry bodies e.g. BIA, ABHI, ABPI, BIVDA
• RDAs, DAs and other regional bodies
• UKTI and FCO ST Network
• Research Councils
• etc